MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
121 hedge funds and large institutions have $407M invested in Merrimack Pharmaceuticals, Inc. in 2014 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 31 increasing their positions, 36 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
14% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 36
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
121
Holding in Top 10
–
Calls
$7.79M
Puts
$5.19M
Top Buyers
| 1 | +$12.7M | |
| 2 | +$12.1M | |
| 3 | +$4.15M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.97M |
| 5 |
Goldman Sachs
New York
|
+$3.35M |
Top Sellers
| 1 | -$9.06M | |
| 2 | -$7.3M | |
| 3 | -$2.6M | |
| 4 |
CCA
Catalyst Capital Advisors
Huntington,
New York
|
-$2.56M |
| 5 |
Morgan Stanley
New York
|
-$2.47M |